Fluid and electrolyte abnormalities.
Patients with cancer are at risk for developing a variety of fluid and electrolyte disturbances caused by the disease process or by complications from therapy. An understanding of the pathophysiology of these potential abnormalities allows the clinician to manage patients expectantly and to avoid severe metabolic disarray by correcting imbalances promptly.
Kapoor
M
M
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Chan
G Z
GZ
D000138:Acidosis / Q000503:physiopathology; D000471:Alkalosis / Q000503:physiopathology; D006801:Humans; D006934:Hypercalcemia / Q000503:physiopathology; D006947:Hyperkalemia / Q000503:physiopathology; D006955:Hypernatremia / Q000503:physiopathology; D006996:Hypocalcemia / Q000503:physiopathology; D007008:Hypokalemia / Q000503:physiopathology; D007010:Hyponatremia / Q000503:physiopathology; D017674:Hypophosphatemia / Q000503:physiopathology; D008274:Magnesium / Q000097:blood; D009369:Neoplasms / Q000150:complications; D015275:Tumor Lysis Syndrome / Q000503:physiopathology; D014883:Water-Electrolyte Imbalance / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy
D008274:Magnesium